Health ❯Chronic Diseases ❯Diabetes ❯Type 2 Diabetes

GLP-1 Receptor Agonists

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

Regulators have updated semaglutide product information to include optic neuropathy as a very rare side effect following new studies on vision risks.

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial

Study Highlights Benefits and Risks of Popular Weight-Loss Drugs

GLP-1 Drug Shows Promise in Slowing Alzheimer's Cognitive Decline